Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Tax ProvisionsTax Rate
Others
Ratios

Lexaria Bioscience (LEXX) Gross Profit (2017 - 2025)

Historic Gross Profit for Lexaria Bioscience (LEXX) over the last 12 years, with Q3 2025 value amounting to $174000.0.

  • Lexaria Bioscience's Gross Profit rose 10714.29% to $174000.0 in Q3 2025 from the same period last year, while for Nov 2025 it was $522000.0, marking a year-over-year increase of 562.46%. This contributed to the annual value of $703203.0 for FY2025, which is 5305.12% up from last year.
  • According to the latest figures from Q3 2025, Lexaria Bioscience's Gross Profit is $174000.0, which was up 10714.29% from $174000.0 recorded in Q2 2025.
  • Lexaria Bioscience's 5-year Gross Profit high stood at $181203.0 for Q4 2024, and its period low was $8310.0 during Q4 2021.
  • Its 5-year average for Gross Profit is $102579.2, with a median of $84000.0 in 2024.
  • In the last 5 years, Lexaria Bioscience's Gross Profit crashed by 9640.54% in 2021 and then surged by 88604.09% in 2022.
  • Lexaria Bioscience's Gross Profit (Quarter) stood at $8310.0 in 2021, then skyrocketed by 886.04% to $81940.0 in 2022, then surged by 78.74% to $146456.0 in 2023, then increased by 23.73% to $181203.0 in 2024, then dropped by 3.98% to $174000.0 in 2025.
  • Its Gross Profit was $174000.0 in Q3 2025, compared to $174000.0 in Q2 2025 and $174000.0 in Q1 2025.